會員登入
註冊
Good News for Diabetes Treatment!
2023-12-01 / GlobalBio & Investment
GoodNewsforDiabetesTreatment!Didyouknowthatevenmobileappsarejoiningthefightagainstdiabetes?Twooutoftheworld'stopthreeinsulinmanufacturershaveteamedupwithaTaiwanesecompany!Divedeeperintotheexciting...
Dr. Ching-Yung Lin : Pioneering Graphen to Power AI Drug Development...
2023-12-01 / GlobalBio & Investment
Dr. Ching-YungLin :Pioneering Graphen toPowerAIDrugDevelopment.Nextyear,anewsubsidiaryisonthehorizon,honinginonProteinKinases. Diveintothefullscooptocatchallthedetails!https://lnkd.in/gst3PyCp #Innova...
Beyond mRNA Vaccines: What's the Next Frontier?
2023-12-01 / GlobalBio & Investment
BeyondmRNAVaccines:What'stheNextFrontier? Everwonderedwhy Moderna isdivingintorarediseasetherapies?Findouttheintriguingstorybehindtheirboldmove!Plus,discoverhowmRNAtherapyisrevolutionizingthedevel...
AusBiotech 2023: Over 22 Countries Delegates, 170 Speakers and 50 Sessions
2023-12-01 / GlobalBio & Investment
AusBiotech2023:Over22CountriesDelegates,170Speakersand50SessionsAustralia’sbiggestweekinbiotech,AusBiotech2023nationalconferenceisheldinBrisbanefrom1-3November.AusBiotech2023launchedwithmorethan...
BioJapan 2023: Taiwan at the Forefront of Regenerative Medicine
2023-12-01 / GlobalBio & Investment
BioJapan2023:TaiwanattheForefrontofRegenerativeMedicine BioJapan2023,Japan'spremierthree-daybiotechnologyevent,kickedoffatthe PACIFICOYokohama ConventionCenteronOctober11th.AroundtwentyTaiwaneseco...
Real-life “Hanten Jutsushiki”! CiRA Director, Jun Takahashi, Utilizes iPSCs for Brain Treatment
2023-12-01 / GlobalBio & Investment
Real-life“HantenJutsushiki”!CiRADirector,JunTakahashi,UtilizesiPSCsforBrainTreatment JunTakahashi,thedirectorofKyotoUniversity'sCenterforiPSCellandApplication(CiRA)andaprominentfigurei...
Taiwan's Cell Therapy: 20 Years of Progress - Reviewing Current Clinical Trials
2023-12-01 / GlobalBio & Investment
Taiwan'sCellTherapy:20YearsofProgress-ReviewingCurrentClinicalTrials Themuch-debatedRegenerativeMedicineActhasbeenthesubjectofongoingdiscussionsformanyyears.Thoughithasconsolidatedfromthreedraftgu...
The Winners of 2023 Best Bio CEO Award held by Globalbio have been revealed!
2023-12-01 / GlobalBio & Investment
TheWinnersof2023BestBioCEOAwardheldbyGlobalbiohavebeenrevealed!Thisyearwehave CytoArm｜Armed-Tcelltherapy, LeadgeneBiomedical,Inc.,and SunWayBiotechCo.,LTD. winningtheawards.Thefirstwinner,CytoArm,feat...
AI Revolutionizing Biomedicine: Recent Advances and Healthcare Applications
2023-12-01 / GlobalBio & Investment
AIRevolutionizingBiomedicine:RecentAdvancesandHealthcareApplicationsAIanditsgenerativecapabilitieshavegainedsignificantattention,particularlyinthefieldofbiomedicine,sinceChatGPT'srisetoprominencei...
Rebuilding Psychological Safety After Drug Allergy: A 4-Step Approach
2023-12-01 / GlobalBio & Investment
RebuildingPsychologicalSafetyAfterDrugAllergy:A4-StepApproachAdrugallergyoccurswhentheimmunesystemreactstoanonprescription,prescription,orherbalmedicine.Patientssufferingfromdrugallergiesexperiencevar...
LuminX Fluorescent Nano-Diamond Platform Achieves in Tracking Lung Injury, Head and Neck Cancer
2023-12-01 / GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】LuminXFluorescentNano-DiamondPlatformAchievesinTrackingLungInjury,HeadandNeckCancer.TheinnovativetrackingplatformofLuminXcombinesnanoscal...
EirGenix's Development Capacity Extends to CDMO and Biosimilars Across the US, Europe, and Taiwan
2023-12-01 / GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】EirGenix'sDevelopmentCapacityExtendstoCDMOandBiosimilarsAcrosstheUS,Europe,andTaiwan. EirGenix(6589.TWO)isoneofthefewcompaniesinAsiat...
